Oragenics Share Price
AMEX: OGEN | Micro Cap | HealthcareOragenics Stock Performance
Oragenics Share Price Chart
Oragenics Quarterly Profit & Loss
All figures in USD
Oragenics Annual Profit & Loss
All figures in USD
Oragenics Balance Sheet
All figures in USD Million
Oragenics Cash Flow
All figures in USD Million
Corporate Actions
About Oragenics
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
Oragenics Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.37 | $0.20 | -45.55% |
Oct 2026 | $0.49 | $0.37 | -24.90% |
Sep 2026 | $0.52 | $0.49 | -7.49% |
Aug 2026 | $0.52 | $0.53 | +6.80% |
Jul 2026 | $0.60 | $0.50 | -13.79% |
Jun 2026 | $0.61 | $0.58 | -4.45% |
May 2026 | $0.63 | $0.61 | +6.49% |
Apr 2026 | $0.57 | $0.57 | +1.79% |
Mar 2026 | $0.81 | $0.56 | -33.01% |
Feb 2026 | $0.81 | $0.84 | +3.47% |
Jan 2026 | $0.82 | $0.81 | +7.59% |
Dec 2025 | $0.85 | $0.75 | -14.66% |